Blackboard
   
Expand
   
Collapse
            
    
            
Search
2017
01
02
02/28/2017
01:00 PM
FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Urothelial Carcinoma for Priority Review
02/09/2017
11:00 AM
Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with Multiple Sclerosis
02/08/2017
03:00 PM
North American Businesses of Merck KGaA, Darmstadt, Germany Certified as 2017 Top Employer
02/02/2017
10:30 AM
Merck KGaA, Darmstadt, Germany, appoints Anke Schenkel as Head of Group Controlling & Risk Management
03
04
05
06
07
08
09
10
11
12
2018
   
Expand
   
Collapse
            
    
            
Search
© Merck KGaA, Darmstadt, Germany